Table 3.
Association between different factors and hearing improvement in patients in this study
| Hearing improvement | Mann-Whitney and Fisher exact tests | ||||
|---|---|---|---|---|---|
| No 7 (35.0%) |
Yes 13 (65.0%) |
p-value | |||
| Age (years) | Median (IQR) | 51.0 (51.0–53.0) | 36.0 (35.0–44.0) | 0.011* | |
| Mean rank | 15.0 | 8.08 | |||
| Sex | Female | N | 1 | 5 | 0.354 |
| % | 14.3% | 38.5% | |||
| Male | N | 6 | 8 | ||
| % | 85.7% | 61.5% | |||
| Onset of HL (months) | Median (IQR) | 3.0 (2.0–3.0) | 1.5 (1.5–2.0) | 0.006* | |
| Mean rank | 15.29 | 7.92 | |||
| Time of starting steroids (days) | Median (IQR) | 21.0 (14.0–21.0) | 7.0 (5.0–14.0) | 0.008* | |
| Mean rank | 15.14 | 8.0 | |||
| General disease | No | N | 3 | 11 | 0.078 |
| % | 42.9% | 84.6% | |||
| Yes | N | 4 | 2 | ||
| % | 57.1% | 15.4% | |||
| HL configuration | Flat | N | 1 | 4 | 0.716 |
| % | 14.3% | 30.8% | |||
| High | N | 3 | 3 | ||
| % | 42.9% | 23.1% | |||
| Low | N | 3 | 6 | ||
| % | 42.9% | 46.2% | |||
*Significant at P < 0.05